Academic Journals Database
Disseminating quality controlled scientific knowledge

Clinical Pharmacology : Advances and Applications

ISSN: 1179--1438
Publisher: Dove Press


ADD TO MY LIST
 
Arginine deprivation therapy for malignant melanoma

Author(s): Yoon JK | Frankel AE | Feun LG | Ekmekcioglu S | Kim KB
Volume: 2013
Issue: default
Year: 2012
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing

Author(s): Thomas RP | Recht L | Nagpal S
Volume: 2013
Issue: default
Year: 2012
Loading regimen required to rapidly achieve therapeutic trough plasma concentration of teicoplanin and evaluation of clinical features

Author(s): Seki M | Yabuno K | Miyawaki K | Miwa Y | Tomono K
Volume: 2012
Issue: default
Year: 2012
Pazopanib for the treatment of soft-tissue sarcoma

Author(s): Heudel P | Cassier P | Derbel O | Dufresne A | Meeus P | Thiesse P | Ranchère-Vince D | Blay JY | Ray-Coquard I
Volume: 2012
Issue: default
Year: 2012
Sedation in the intensive care setting

Author(s): Hughes CG | McGrane S | Pandharipande PP
Volume: 2012
Issue: default
Year: 2012
Erratum

Author(s): Samtani MN | Sheehan JJ | Fu D-J | Remmerie B | Sliwa JK | Alphs L
Volume: 2012
Issue: default
Year: 2012
Erratum

Author(s): Barrese V | Miceli F | Soldovieri MV | Ambrosino P | Iannotti FA | Cilio MR | Taglialatela M
Volume: 2012
Issue: default
Year: 2012
Two-way pharmacokinetic interaction studies between saxagliptin and cytochrome P450 substrates or inhibitors: simvastatin, diltiazem extended-release, and ketoconazole

Author(s): Patel C | Li L | Girgis S | Kornhauser D | Frevert E | Boulton D
Volume: 2011
Issue: default
Year: 2011
Detemir as a once-daily basal insulin in type 2 diabetes

Author(s): Nelson SE
Volume: 2011
Issue: default
Year: 2011
Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions

Author(s): Mahamid M | Mader R | Safadi R
Volume: 2011
Issue: default
Year: 2011
Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report

Author(s): Ohanian M | Cable C | Halka K
Volume: 2011
Issue: default
Year: 2011
Drug-resistant tuberculosis: emerging treatment options

Author(s): Adhvaryu MR | Vakharia BC
Volume: 2011
Issue: default
Year: 2011
Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response

Author(s): Kreutz RP | Nystrom P | Kreutz Y | Miao J | Desta Z | Breall JA | Li L | Chiang C | Kovacs R | Flockhart DA | Jin Y
Volume: 2012
Issue: default
Year: 2012
Phase 1 clinical study of the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid

Author(s): Gandy JJ | Meeding JP | Snyman JR | Janse van Rensburg CE
Volume: 2012
Issue: default
Year: 2012
Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial

Author(s): Hashemi SN | Ghafarian Shirazi HR | Mohammadi A | Zadeh-Bagheri GH | Noorian KH | Malekzadeh M
Volume: 2012
Issue: default
Year: 2012
Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician

Author(s): Guy Hans | Dominique Robert | Johanna Verhulst | et al
Volume: 2010
Issue: default
Year: 2010
Nanoparticle-labeled stem cells: a novel therapeutic vehicle

Author(s): Abir O El-Sadik | Afaf El-Ansary | Sherif M Sabry
Volume: 2010
Issue: default
Year: 2010
The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein–Barr virus disease

Author(s): Heather E Vezina | Richard C Brundage | Thomas E Nevins | et al
Volume: 2010
Issue: default
Year: 2009
A case of cephalothin-associated urolithiasis

Author(s): Ivan WM Lim | Peter JO Stride | Robert L Horvath
Volume: 2011
Issue: default
Year: 2011
Immunocytokines: a review of molecules in clinical development for cancer therapy

Author(s): List T | Neri D
Volume: 2013
Issue: Supplement 1
Year: 2013
Use of ipilimumab in the treatment of melanoma

Author(s): Acharya UH | Jeter JM
Volume: 2013
Issue: Supplement 1
Year: 2013
Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinoma

Author(s): Brueseke TJ | Tewari KS
Volume: 2013
Issue: Supplement 1
Year: 2013
Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia

Author(s): Portell CA | Wenzell CM | Advani AS
Volume: 2013
Issue: Supplement 1
Year: 2013
High-dose, short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure

Author(s): Yabuno K | Seki M | Miyawaki K | Miwa Y | Tomono K
Volume: 2013
Issue: Issue 1
Year: 2013
Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model

Author(s): Lozano R | Domeque N | Apesteguia AF
Volume: 2013
Issue: Issue 1
Year: 2013
Single-dose fentanyl sublingual spray for breakthrough cancer pain

Author(s): Taylor DR
Volume: 2013
Issue: Issue 1
Year: 2013
Synthetic cathinone abuse

Author(s): Capriola M
Volume: 2013
Issue: Issue 1
Year: 2013
Impact of denosumab on bone mass in cancer patients

Author(s): Brown-Glaberman U | Stopeck AT
Volume: 2013
Issue: Issue 1
Year: 2013
Clinical effectiveness of baclofen for the treatment of alcohol dependence: a review

Author(s): Brennan JL | Leung JG | Gagliardi JP | Rivelli SK | Muzyk AJ
Volume: 2013
Issue: Issue 1
Year: 2013
Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure–response analysis of a Phase III study

Author(s): Wang X | Roy A | Hochhaus A | Kantarjian HM | Chen TT | Shah NP
Volume: 2013
Issue: Issue 1
Year: 2013
Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: a review of ticagrelor

Author(s): Davis EM | Knezevich JT | Teply RM
Volume: 2013
Issue: Issue 1
Year: 2013
Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor

Author(s): Upreti VV | Song Y | Wang J | Byon W | Boyd RA | Pursley JM | LaCreta F | Frost CE
Volume: 2013
Issue: Issue 1
Year: 2013
Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven®)

Author(s): Bartosh NS | Tomlin T | Cable C | Halka K
Volume: 2013
Issue: Issue 1
Year: 2013
Effect of statin therapy on vaspin levels in type 2 diabetic patients

Author(s): Al-Azzam SI | Alzoubi KH | Abu Abeeleh J | Mhaidat NM | Abu-Abeeleh M
Volume: 2013
Issue: Issue 1
Year: 2013
Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent

Author(s): Gillian W Reierson | Claudio A Mastronardi | Julio Licinio | et al
Volume: 2009
Issue: Default
Year: 2009
Save time & money - Smart Internet Solutions      Why do you need a reservation system?